The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older with glycogen storage disease type Ia (GSDIa)

Evidence test

FinchFile doesn't ask you to trust us. It shows you the evidence. Real means this claim passed FinchFile's evidence test — not that we are an authority on truth.

• FDA ↗Primary documentFDASupports

  The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 yea

  Dose Check · Sep 14, 5:52 PM

How this was checked

A headline is rarely one claim. This one was split into 2 separate checkable claims, and each was routed to the kind of record that would prove or disprove it. The story's stamp is a function of those parts, not of the headline's wording.

1. Did it happenReal

   Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr)

   Needs a primary record of the event itself.

2. Is the number rightReal

   the first-ever treatment for adults and children 8 years of age and older with glycogen storage disease type Ia (GSDIa)

   Needs the figure in a primary source, not a retelling.

What each source said

• FDATier 1Supports

  FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

• FDATier 1Supports

  FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Related stamps

More FinchFile checks in Health.

• DependsThere have been six hospitalizations related to E. coli illnesses linked to frozen blueberries, the Food and Drug Administration said.Depends
• DependsSTAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and moreDepends
• RealA 40-year-old woman died on Saturday from complications associated with measles, the coroner reported.Real